MOBILE TELEMONITORING FOR EARLY DIAGNOSIS OF CHANGES IN PATIENT CONDITIONS
https://doi.org/10.29001/2073-8552-2016-31-2-92-95
Abstract
Remote monitoring of patients with implanted cardiac pacemakers (ICP) and with implanted cardioverter defibrillators (ICD) is a reliable alternative to the ambulatory medical exams. It allows for early detection of changes in patient condition and cardiac stimulation system, saves patient time required for unnecessary ambulatory exams, and decreases physician workload. Reduction of time spent for planned visits to a doctor, on the one hand, and early diagnosis of life(threatening complications, on the other hand, provide significant economic effect and result in better quality of patient life. Aim: The aim of the study was to analyze the advantages of mobile telemonitoring for detection of abnormal work of stimulation system, complications, and undiagnosed disorders in heart rhythm in study patients. Materials and Methods. The study included 42 patients aged 65.71±11.30 years (Me)=67.00 years including 21 men (50%) with different diseases requiring implantation of two(chamber ICP. All patients were divided into 2 groups. Follow up period lasted for one year. Results: Follow up based on remote monitoring at early stage allowed for detection of the changes requiring medical intervention. Most patients from two groups did not have any changes in their condition and did not require regular ambulatory examination. Besides, the study found the intergroup differences between the numbers of hospitalizations and ambulatory visits during the year. Conclusions. Remote monitoring allows for detection of changes in patient condition and in ICP system work earlier than standard follow up examinations suggesting the advantages of remote telemonitoring.
About the Authors
E. A. ArchakovRussian Federation
S. N. Krivolapov
Russian Federation
S. Yu. Usenkov
Russian Federation
R. E. Batalov
Russian Federation
S. V. Popov
Russian Federation
M. S. Khlynin
Russian Federation
References
1. Halimi F., Cantu F. Remote monitoring for active cardiovascular implantable electronic devices: a European survey. – 2010 Dec. – Vol. 12(12). – P. 1778–1780 [Electronic resource] – doi: 10.1093/europace/euq399.
2. Хасанов И.Ш. Телемониторинг имплантируемых устройств – новые возможности диагностики и лечения аритмий и сердечной недостаточности // Сибирский медицинский журнал (Томск). – 2009. – Т. 24, вып. 1, № 1. – С. 15–20.
3. Varma N., Epstein A.E., Irimpen A. Efficacy and safety of automatic remote monitoring for implantable cardioverter( defibrillator follow(up: The Lumos(T safely reduces routine office device follow(up (TRUST) // Circulation. – 2010. – Vol. 122. – P. 325–332.
4. Mabo P. Home Monitoring for Pacemaker Follow(Up: The First Prospective Randomised Trial. Presentation at Cardiostim 2010, Nice Acropolis, France, June 16–19, 2010.
5. Wetzel U., Geller C., Kautzner J. et al. Remote follow(up for. ICD( therapy in patients meeting Madit II criteria. The REFORM trial (abstract) // Heart Rhythm. – 2009. – P. 221–229 [Electronic resource] – doi: 10.1093/europace/euq447.
6. Halimi F., Cantu F. Remote monitoring for active cardiovascular implantable electronic devices: a European survey // Europace 12, European Heart Rhythm Association (EHRA) Scientific Initiatives Committee – 2010. – P. 1778–1780. – [Electronic resource] – doi: 10.1093/europace/euq399.
7. Kacet S., Guйdon(Moreau L., Hermida J.(S. et al. Safety and effectiveness of ICD follow(up using remote monitoring: ECOST: safety of implantable cardioverter defibrillator follow(up using remote Monitoring: a randomized controlled Trial, Presented at: European Society of Cardiology Congress 2011, Paris, France, 27–31, August 2011.
8. Hindricks G. et al. Implant(based multiparameter telemonitoring of patients with heart failure (IN(TIME): a randomised controlled trial // Lancet. – 2014. – Vol. 384(9943). – P. 583– 590.
9. Mabo P., Victor F., Bazin P. et al. Randomized Trial of Long(Term Remote Monitoring of Pacemaker Recipients (The COMPAS trial Investigators) // Eur. Heart J. – 2011. – Vol. 57. – P. 1181–1189.
10. Perings C., Bauer W.R., Bondke H.(J. et al. Remote monitoring of implantable(cardioverter defibrillators: results from the Reliability of IEGM Online Interpretation (RIONI) study // Europace. – 2011. – Vol. 13. – P. 221–229.
11. Ricci R.P., Morichelli L., Quarta L. et al. Long(term patient acceptance of and satisfaction with implanted device remote monitoring // Europace. – 2010. – Vol. 12. – P. 674–679.
12. Zartner P.A. et al. Telemonitoring with implantable electronic devices in young patients with congenital heart diseases // Europace. – 2012. – P. 1030–1037.
Review
For citations:
Archakov E.A., Krivolapov S.N., Usenkov S.Yu., Batalov R.E., Popov S.V., Khlynin M.S. MOBILE TELEMONITORING FOR EARLY DIAGNOSIS OF CHANGES IN PATIENT CONDITIONS. Siberian Journal of Clinical and Experimental Medicine. 2016;31(2):92-95. (In Russ.) https://doi.org/10.29001/2073-8552-2016-31-2-92-95